Teva (Israel) Richard Francis New CEO – D/E Naftali Hirschl, PhD. Business 23.11.202223.11.2022 2 Minutes Teva Pharmaceutical Industries Ltd. (“Teva” or the “Company”) (NYSE and TASE: TEVA), today announced that the Company’s Board of Directors has appointed Richard Francis as President and Chief Executive Officer, effective January 1, 2023. ... Please register here, or login below. Username or E-mail Password Remember Me Forgot Password Published by Naftali Hirschl, PhD. View all posts by Naftali Hirschl, PhD. Published 23.11.202223.11.2022